Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial

Prescott G. Woodruff, Wissam Chatila, John E. Connett, Gerard J. Criner, Jeffrey L. Curtis, Mark T. Dransfield, Meilan K. Han, Stephen C. Lazarus, Nathaniel Marchetti, Thomas J. Rogers, Paul D. Scanlon, Don D. Sin, Helen Voelker, Christine Wendt, Richard K. Albert

Research output: Contribution to journalLetter

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalEuropean Respiratory Journal
Volume43
Issue number1
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Woodruff, P. G., Chatila, W., Connett, J. E., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., Marchetti, N., Rogers, T. J., Scanlon, P. D., Sin, D. D., Voelker, H., Wendt, C., & Albert, R. K. (2014). Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial. European Respiratory Journal, 43(1), 295-298. https://doi.org/10.1183/09031936.00140613